These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1412197)
1. Familial elevation of plasma histidine-rich glycoprotein. A case associated with recurrent venous thrombosis and high PAI-1 levels. Falkon L; Gari M; Montserrat I; Borrell M; Fontcuberta J Thromb Res; 1992 May; 66(2-3):265-70. PubMed ID: 1412197 [No Abstract] [Full Text] [Related]
2. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism. Angles-Cano E; Gris JC; Loyau S; Schved JF J Lab Clin Med; 1993 May; 121(5):646-53. PubMed ID: 8478593 [TBL] [Abstract][Full Text] [Related]
3. Association of protein S deficiency with thrombosis in a kindred with increased levels of plasminogen activator inhibitor-1. Bolan CD; Krishnamurti C; Tang DB; Carrington LR; Alving BM Ann Intern Med; 1993 Oct; 119(8):779-85. PubMed ID: 8379599 [TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic abnormalities. A Spanish multicenter study ebt.I on 443 patients with venous thromboembolic disease. Falkon L; Borrell M; Sala N; Felez J; Martín S; Grau E; Fontcuberta J Thromb Res; 1992 May; 66(4):455-60. PubMed ID: 1412209 [No Abstract] [Full Text] [Related]
5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167 [TBL] [Abstract][Full Text] [Related]
6. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis. Jørgensen M; Bonnevie-Nielsen V Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670 [TBL] [Abstract][Full Text] [Related]
7. Does low protein concentration of tissue-type plasminogen activator predict a low risk of spontaneous deep vein thrombosis? Gram J; Sidelmann J; Jespersen J Thromb Haemost; 1995 Aug; 74(2):718-21. PubMed ID: 8585012 [TBL] [Abstract][Full Text] [Related]
8. Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? A study in 203 patients with familial or sporadic venous thrombophilia. Engesser L; Brommer EJ; Kluft C; Briët E Thromb Haemost; 1989 Sep; 62(2):673-80. PubMed ID: 2683188 [TBL] [Abstract][Full Text] [Related]
9. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039 [TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women. Häggroth L; Mattsson C; Felding P; Nilsson IM Thromb Res; 1986 Jun; 42(5):585-94. PubMed ID: 3087015 [TBL] [Abstract][Full Text] [Related]
11. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462 [TBL] [Abstract][Full Text] [Related]
13. A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis. Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B Scand J Haematol; 1982 Sep; 29(3):217-23. PubMed ID: 6890710 [TBL] [Abstract][Full Text] [Related]
14. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
15. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232 [TBL] [Abstract][Full Text] [Related]
16. Deficiency of protein C in congenital thrombotic disease. Griffin JH; Evatt B; Zimmerman TS; Kleiss AJ; Wideman C J Clin Invest; 1981 Nov; 68(5):1370-3. PubMed ID: 6895379 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen activators and plasminogen activator inhibitor before and after surgery in patients with and without gastric malignancy. Rahr HB; Sørensen JV; Larsen JF; Jensen FS; Bredahl C Haemostasis; 1995; 25(5):248-56. PubMed ID: 7489964 [TBL] [Abstract][Full Text] [Related]